Hemorrhage Visible on MRI but Not on CT: Clinical Significance
When hemorrhage is visible on MRI but not on CT, this most commonly indicates either a very small/subtle acute hemorrhage (such as hemorrhagic transformation of ischemic stroke), a chronic/old hemorrhage (microbleeds or remote bleeding), or a subacute hemorrhage where CT sensitivity has declined.
Understanding the Imaging Discrepancy
The key to interpreting this finding lies in understanding the relative sensitivities of these modalities at different time points:
Acute Hemorrhage Detection
- CT remains the gold standard for hyperacute hemorrhage (first few hours) and is highly sensitive for detecting fresh blood 1
- MRI (particularly gradient echo and T2 susceptibility-weighted sequences) is equally sensitive to CT for acute hemorrhage* but provides additional information 1, 2
- When both modalities are performed acutely, they show 96% concordance for acute hemorrhage 2
When MRI Detects What CT Misses
The most clinically relevant scenarios include:
1. Hemorrhagic Transformation of Ischemic Stroke
- This is the most common acute scenario where MRI is positive but CT is negative
- In a prospective multicenter study, 4 cases of acute hemorrhagic transformation were detected on MRI but missed on CT 2
- These hemorrhages are typically small and may not reach the density threshold for CT detection
2. Chronic/Remote Hemorrhage
- MRI is far superior to CT for detecting old hemorrhages, particularly microbleeds
- In the same study, 49 patients had chronic hemorrhage visible on MRI but not on CT 2
- Hemosiderin deposition from old bleeds creates susceptibility artifacts on MRI that persist indefinitely but are invisible on CT 3, 4
3. Very Small Acute Hemorrhages
- Microhemorrhages or petechial bleeding may fall below CT's detection threshold
- MRI's superior soft tissue contrast and susceptibility effects make it more sensitive for these lesions
Clinical Implications and Management
If the Clinical Presentation is Acute (within hours):
Consider hemorrhagic transformation of an ischemic infarct as the primary diagnosis 2. This requires:
- Careful review of the MRI for evidence of underlying ischemic stroke
- Assessment of anticoagulation status and reversal needs
- Monitoring for expansion, though these hemorrhages are typically small
If Timing is Uncertain or Subacute:
The hemorrhage is likely older than initially suspected. The evolution of blood products affects imaging:
- CT sensitivity decreases after the first few days as the hematoma becomes isodense
- MRI remains sensitive throughout all stages of hemorrhage evolution due to paramagnetic properties of hemoglobin breakdown products 3, 4
Critical Pitfall to Avoid:
Do not assume all MRI-detected hemorrhages are clinically insignificant simply because CT was negative. While many represent chronic microbleeds, some represent acute hemorrhagic transformation requiring management adjustments, particularly regarding anticoagulation 2.
Practical Algorithm for Interpretation
When faced with this discrepancy:
Determine the clinical timeline: When did symptoms begin? When was each scan performed?
Review the MRI sequences carefully:
- Gradient echo/T2* sequences showing "blooming" suggest hemorrhage
- T1 and T2 characteristics help determine age 4
Look for associated findings:
- Surrounding edema or mass effect suggests acute/subacute hemorrhage
- Multiple scattered microbleeds suggest chronic small vessel disease
- Adjacent ischemic changes suggest hemorrhagic transformation 2
Correlate with clinical status:
- Acute neurological deterioration with MRI-only hemorrhage warrants treating as acute
- Stable patient with incidental finding likely represents chronic hemorrhage
Consider underlying etiology: MRI is superior for identifying vascular malformations, tumors, and other structural causes of hemorrhage 1, 5
The discrepancy between CT and MRI findings provides valuable diagnostic information rather than representing a contradiction—it typically reflects either the superior sensitivity of MRI for small/chronic hemorrhages or the timing-dependent evolution of blood products on imaging.